Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1998-03-16
1999-08-03
Davenport, Avis M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530326, 530327, 530328, 514 13, 514 14, 514 15, 514 16, A61K 3800
Patent
active
059325453
ABSTRACT:
Peptides having the formula:
REFERENCES:
Journal of Peptide Research, vol. 50, No. 3 (Sep. 1997), pp. 210-221, Guo et al., "Antiproliferative and Antitumor Activities of D-Reverse Peptides Derived from the Second Type-1 Repeat of Thrombospondin-1".
Bouck Noel P.
Dawson David W.
Henkin Jack
Schneider Andrew J.
Abbott Laboratories
Davenport Avis M.
Steele Gregory W.
LandOfFree
Antiangiogenic drug to treat cancer, arthritis and retinopathy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antiangiogenic drug to treat cancer, arthritis and retinopathy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiangiogenic drug to treat cancer, arthritis and retinopathy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-849452